A case of unilateral ovarian fibrothecoma and pelvic aggressive angiomyxoma with a concurrent diagnosis:  Ovarian fibrothecoma and angiomyxoma

İbrahim Karadağ; Özgür Koçak; Fatih Şahin; Güven Güney; Serdar Karakaya

doi:10.5281/zenodo.11200318

Authors

İbrahim Karadağ Hitit University Erol Olçok Training and Research Hospital, Department of Medical Oncology, Çorum, Turkey https://orcid.org/0000-0002-2356-6790
Özgür Koçak Hitit University Erol Olçok Training and Research Hospital, Department of Gynecology and Obstetrics, Çorum, Turkey https://orcid.org/0000-0002-3906-9422
Fatih Şahin Hitit University Erol Olçok Training and Research Hospital, Department of General Surgery, Çorum, Turkey https://orcid.org/0000-0002-6505-5884
Güven Güney Hitit University Faculty of Medicine, Department of Pathology, Çorum, Turkey https://orcid.org/0000-0001-8324-2870
Serdar Karakaya Health Science University, Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey https://orcid.org/0000-0002-2111-7131

DOI:

https://doi.org/10.5281/zenodo.11200318

Keywords:

Aggressive angiomyxoma, fibrothecoma, pelvic tumors

Abstract

Aggressive angiomyxoma (AA) is a rare mesenchymal tumor that is more common in women and can cause local recurrences, usually originating from the pelvis. Surgical excision is the main treatment method. In patients who cannot be completely excised or who relapse, hormone therapy and radiotherapy can be other options. A rare subtype of ovarian sex-cord stromal tumor is called fibrothecoma (FT). Early diagnosis is common and surgical excision is typically enough for treatment. In this report, we describe the case of a 56-year-old woman who was simultaneously diagnosed with two distinct cancers.

References

Magtibay PM, Salmon Z, Keeney GL, Podratz KC. Aggressive angiomyxoma of the female pelvis and perineum: a case series. Int J Gynecol Cancer. 2006;16:396-01

Fetsch JF, Laskin WB, Lefkowitz M, Kindblom LG, Meis-Kindblom JM. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients. Cancer. 1996;78:79-90.

Bai HM, Yang JX, Huang HF, Cao DY, Chen J, Yang N, et al. Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis. Eur J Surg Oncol 2013;39:1101-08

Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin Broto J, et al. Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study. Oncologist. 2019;24:e536-41

Krishnan D, Kumar K, Thomas AA. Unilateral ovarian fibrothecoma with menorrhagia. Malays J Pathol. 2014;36:55-8.

Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol. 2005;97:519-23.

Jung SE, Rha SE, Lee JM, Park SY, Oh SN, Cho KS, et al. CT and MRI findings of sex cord-stromal tumor of the ovary. AJR. 2005;185:207–15.

Sylvester DC, Kortequee S, Moor JW, Woodhead CJ, Maclennan KA. Aggressive angiomyxoma of larynx: case report and literature review. J Laryngol Otol. 2010;124:793-5.

Wang Z, Liu Y, Yang L, Gu L, He Y, Huang D, et al. Maxillary aggressive angiomyxoma showing ineffective to radiotherapy: a rare case report and review of literature. Int J Clin Exp Pathol. 2015;8:1063-7.

Zou R, Xu H, Shi Y, Wang J, Wang S, Zhu L. Retrospective analysis of clinicopathological features and prognosis for aggressive angiomyxoma of 27 cases in a tertiary center: a 14-year survey and related literature review. Arch Gynecol Obstet. 2020;302:219-29.

Rawlinson NJ, West WW, Nelson M, Bridge JA. Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer Genet Cytogenet. 2008;181:119-24

Peterknecht E, Agerbak E, Mohamedahmed A, Stonelake S, Kulkarni K, Peravali R, et al. Aggressive angiomyxoma of the ischioanal fossa in a post-menopausal woman. Ann R Coll Surg Engl. 2021;103:e59-64.

Kelley SR. Robotic extralevator excision of a retrorectal giant aggressive angiomyxoma. Obstet Gynecol Sci. 2018;61:693.

Hajjar R, Alharthi M, Richard C, Gougeon F, Loungnarath R. Pelvic Aggressive Angiomyxoma: Major Challenges in Diagnosis and Treatment. Cureus. 2019;11:e4419.

Chan YM, Hon E, Ngai SW, Ng TY, Wong LC. Aggressive angiomyxoma in females: is radical resection the only option? Acta Obstet Gynecol Scand. 2000;79:216-20.

Beuran M, Ciubotaru C, Runcanu A, Enache V, Negoi I. Surgical Resection of Retroperitoneal Aggressive Angiomyxoma: Case Report and Review of the Literature. Cureus. 2017;9:e1485.

Rawlinson NJ, West WW, Nelson M, Bridge JA. Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature. Cancer Genet Cytogenet. 2008;181:119-24

Sutton BJ, Laudadio J. Aggressive angiomyxoma. Arch Pathol Lab Med. 2012;136:217-21.

Chechia A, Attia L, Temime RB, Makhlouf T, Koubaa A. Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas. Am J Obstet Gynecol. 2008;199:e1–4.

Salemis NS, Panagiotopoulos N, Papamichail V, Kiriakopoulos K, Niakas E. Bilateral ovarian fibrothecoma. An uncommon cause of a large pelvic mass. Int J Surg Case Rep. 2011;2:29-31.

Liu H, Hao SH, Li WM. Giant malignant ovarian fibrothecoma involved with retroperitoneal structures mimicking a retroperitoneal sarcoma. Arch Gynecol Obstet. 2009;279:763–5.

Bazot M, Ghossain MA, Buy JN, Deligne L, Hugol D, Truc JB, et al. Fibrothecomas of the ovary: CT and US findings. J Comput Assist Tomogr. 1993;17:754-9.